Skip to content
November 05, 2024

Investment information for the new generation

Search

ADK.V

Today Equity.Guru founder, Chris Parry, speaks with Stefan Quenneville, Director of Life Sciences and Biotech Research at Echelon Wealth Partners, to get his take on Diagnos (ADK.V), a Canadian…
Diagnos (ADK.V) announced that their artificial intelligence program delivered world-class results in the GAMMA (Glaucoma GrAding from Multi-Modality imAges) contest, held alongside The Medical Imaging Computing and Computer-Assisted Intervention…
Diagnos (ADK.V) announced today that it has signed a 7-year contract with Juarez Health & Medical Tourism Cluster (“Cluster”), headquartered in Ciudad Juarez located in the State of Chihuahua,…
Diagnos (ADK.V) announced today that it has signed a 3-year contract with Cielo Vista Eye Clinic in Mexico. According to the contract, Diagnos will supply its CARA platform to…
In this episode, we talk about DIAGNOS (ADK.V), a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging, and traditional data mining thereby improving decision…
Chris Parry speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an in-depth look at how their diabetic retinopathy screening services work and what it means…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Diagnos (ADK.V) is definitely one of the companies with the coolest AI tech I have come across. I would use the word disruptive. And I like disruptive. I am…
Diagnos (ADK.V) today announced a contract renewal to provide its telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics for an additional three-year period. “This contract…